|
It was reported that thrombosis occurred.A left atrial appendage (laa) closure procedure was performed, and a 31mm watchman flx pro closure device was implanted on (b)(6) 2024.The patient was discharged.The patient had a follow up computed tomography (ct) scan performed on (b)(6) 2026, to evaluate a non-mobile thrombus located towards the limbus side that was previously discovered on a computed tomography (ct) performed on (b)(6) 2025, and to evaluate the contrast patency of the closure device as well.The watchman clinical evaluated the ct that was done on (b)(6) 2026 and asked to also see the ct from on (b)(6) 2025, to be able to compare previous ct with the current ct.Based on what the watchman clinical had seen, both of the cts were sent to the therapy operations team for additional evaluation as well.The watchman clinical has not heard back from the therapy operations team yet to get their impression of the ct.During the procedure, the closure device met all of position, anchor, size and seal (pass) criteria the day of implant.After evaluating the cts, the closure device still meets all of pass criteria.Before implant, the patient was on eliquis and aspirin (asa).Now the patient is still on xarelto.It is unknown and unavailable per the facility right now as to what treatment will be done.The physician is waiting on the report from the watchman clinical and therapy ops team to see what the next steps will be for the patient.
|